Vir Biotechnology Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +482.6% | -18.1% | +10,640.9% | +1,334.4% | +47.5% | -94.7% | -13.9% | -7.6% | |
| – | +60.3% | +42.7% | +110.8% | +70.4% | +20.8% | -7.8% | -16.4% | -97.6% | |
| – | – | – | +10,640.9% | +661.5% | +71.1% | -148.9% | – | – | |
| – | +60.3% | +48.1% | +103.7% | +48.1% | +5.9% | +22.1% | -12.6% | -14.6% | |
| – | +34.3% | +29.1% | +88.7% | +126.7% | +0.6% | +7.4% | -31.5% | -22.6% | |
| – | +46.4% | +49.5% | +108.9% | -56.9% | +0.6% | +22.2% | -7.6% | +187.2% | |
| – | – | – | – | – | +98.0% | -182.1% | – | – | |
| – | – | – | -52.2% | +7,061.1% | -32.9% | – | – | – | |
| – | – | – | – | – | +37.2% | -183.3% | – | – | |
| – | – | – | -135.1% | – | +1,023.8% | -105.5% | – | – | |
| – | – | – | – | – | -2.4% | -219.2% | – | – | |
| – | – | – | – | +8.0% | +37.0% | -184.3% | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.